Who was surprised by the decision?

Health Canada authorizes Moderna's phase 1 trial for an mRNA vaccine targeting the Bundibugyo strain of Ebola, with Canada being the second country to approve it.

• Option 1: The scientists behind the research were shocked
• Option 2: The other countries have been working on similar trials independently